ATH 33.3% 0.4¢ alterity therapeutics limited

Ann: Expanded ATH434 Phase 2 Clinical Development Program, page-29

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 109 Posts.
    lightbulb Created with Sketch. 9
    Frustrating. News after 3 months of silence. When people were expecting good news about start of P2, turns out it is news about delay carefully wrapped in BS. Now we have to wait for 5 more months. And nothing on PBT2. arghhh!!
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.